{
 "PrintNo":"S8194","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2022-02-01T12:48:06.607342Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-02-01","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2022-02-01","Chamber":"SENATE"}],
 "Sponsors":[{"ID":372,"Name":"Neil D. Breslin","Short":"BRESLIN"},{"ID":1101,"Name":"John E. Brooks","Short":"BROOKS"}],
 "Title":"Requires notice of adverse step therapy determinations",
 "Summary":"Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination.",
 "LawSection":"Insurance Law","LawCode":"Amd §§4902 & 4903, Ins L; amd §§4902 & 4903, Pub Health L",
 "ActClause":"AN ACT to amend the insurance law and the public health law, in relation to requiring notice of adverse step therapy determinations",
 "SameAsPrintNo":"A9265-2021"
}